 Trials show Avastin , which is used in several other cancers , gives women around four months ' extra life .
The drug plus chemotherapy has now been licensed by European regulators .
It has been available in England via the CDF since last licensing .
Nearly 3,000 women are diagnosed with cervical cancer in the UK each year .